Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis von Robinson, Andrew P., Zhang, Joanne Zhongyan, Titus, Haley E., Karl, Molly, Merzliakov, Mikhail, Dorfman, Adam R., Karlik, Stephen, Stewart, Michael G., Watt, Richard K., Facer, Benjin D., Facer, Jon D., Christian, Noah D., Ho, Karen S., Hotchkin, Michael T., Mortenson, Mark G., Miller, Robert H., Miller, Stephen D.

Volltext

Gold Coast diagnostic criteria: Implications for ALS diagnosis and clinical trial enrollment von Vucic, Steve, Ferguson, Toby A., Cummings, Catherine, Hotchkin, Michael T., Genge, Angela, Glanzman, Robert, Roet, Kasper C. D., Cudkowicz, Merit, Kiernan, Matthew C.

Volltext

Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catal... von Vucic, Steve, Kiernan, Matthew C, Menon, Parvathi, Huynh, William, Rynders, Austin, Ho, Karen S, Glanzman, Robert, Hotchkin, Michael T

Volltext

A Mechanism Underpinning the Bioenergetic Metabolism‐Regulating Function of Gold Nanocatalysts (Small 8/2024) von Wang, Zixin, Henriques, Alexandre, Rouvière, Laura, Callizot, Noëlle, Tan, Lin, Hotchkin, Michael T., Rossignol, Rodrigue, Mortenson, Mark G., Dorfman, Adam R., Ho, Karen S., Wang, Hui

Volltext

Evidence of brain target engagement in Parkinson's disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials von Ren, Jimin, Rynders, Austin, Evan, Jacob, Evan, Jeremy, Ligozio, Shelia, Ho, Karen S, Sguigna, Peter V, Glanzman, Robert, Hotchkin, Michael T, Dewey, Jr, Richard B, Greenberg, Benjamin M

Volltext

A Mechanism Underpinning the Bioenergetic Metabolism‐Regulating Function of Gold Nanocatalysts von Wang, Zixin, Henriques, Alexandre, Rouvière, Laura, Callizot, Noëlle, Tan, Lin, Hotchkin, Michael T., Rossignol, Rodrigue, Mortenson, Mark G., Dorfman, Adam R., Ho, Karen S., Wang, Hui

Volltext

Correction: Evidence of brain target engagement in Parkinson's disease and multiple sclerosis by the investigational nanomedicine, CNM- Au8, in the REPAIR phase 2 clinical trials von Ren, Jimin, Dewey, 3rd, Richard B, Rynders, Austin, Evan, Jacob, Evan, Jeremy, Ligozio, Shelia, Ho, Karen S, Sguigna, Peter V, Glanzman, Robert, Hotchkin, Michael T, Dewey, Jr, Richard B, Greenberg, Benjamin M

Volltext

Multicenter expanded access program for access to investigational products for amyotrophic lateral sclerosis von Neel, Dylan V., Baselga‐Garriga, Clara, Benson, Molly, Keegan, Mackenzie, Chase, Marianne, D'Agostino, Derek, Drake, Kristin, Hagar, Jennifer Linn, Hasenoehrl, Meredith Gibbons, Kulesa‐Kelley, Jennifer, Leite, Alex, Mohapatra, Silpa, Portaro, Susanna Marie, Pothier, Lindsay M., Rosenthal, Jesse, Sherman, Alexander V., Yu, Hong, McCaffrey, Alexandra, Ho, Doreen, Luppino, Sarah, Bedlack, Richard, Heitzman, Daragh, Ajroud‐Driss, Senda, Katz, Jonathan, Felice, Kevin, Whitaker, Charles, Ladha, Shafeeq, Alameda, Gustavo, Locatelli, Eduardo, Qureshi, Irfan A., Hotchkin, Michael T., Hayden, Michael R., Cudkowicz, Merit E., Babu, Suma, Berry, James D., Paganoni, Sabrina

Volltext

Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension von Vucic, Steve, Menon, Parvathi, Huynh, William, Mahoney, Colin, Ho, Karen S., Hartford, Alan, Rynders, Austin, Evan, Jacob, Evan, Jeremy, Ligozio, Shelia, Glanzman, Robert, Hotchkin, Michael T., Kiernan, Matthew C.

Volltext

VISIONARY-MS Top-line Results: A Phase 2, Randomized, Double-Blind, Parallel Group, Placebo-controlled Study to Assess the Safety and Efficacy of CNM-Au8, a Catalytically Active Go... von Barnett, Michael, Beadnall, Heidi, Klistorner, Alexander, Sergott, Robert, Greenberg, Benjamin, Rynders, Austin, Ho, Karen, Evan, Jacob, Evan, Jeremy, McBride, Ryan, Hartford, Alan, Glanzman, Robert, Hotchkin, Michael

Volltext

Evidence for Survival Benefit in ALS with CNM-Au8 Treatment Across Three Study Populations (P8-8.004) von Berry, James, Maragakis, Nicholas, Paganoni, Sabrina, Quintana, Melanie, Macklin, Eric, Saville, Benjamin, Andrews, Jinsy, Shefner, Jeremy, Detry, Michelle, Menon, Parvathi, Huynh, William, Mahoney, Colin, Stommel, Elijah, Hall, Meghan, Connolly, Mariah, Kittle, Gale, Chase, Marianne, Sherman, Alexander, Yu, Hong, Pothier, Lindsay, Drake, Kristin, Chibnik, Lori, Bind, Marie-Abele, Vestrucci, Matteo, Glanzman, Robert, Hotchkin, Michael, Vucic, Steve, Kiernan, Matthew, Cudkowicz, Merit, Investigators, RESCUE-ALS

Volltext

Results from the first four regimens of the HEALEY ALS Platform Trial (PL5.004) von Paganoni, Sabrina, Berry, James, Quintana, Melanie, Macklin, Eric, Saville, Benjamin, Andrews, Jinsy, Shefner, Jeremy, Fournier, Christina, Babu, Suma, Maragakis, Nicholas, Oskarsson, Bjorn, Detry, Michelle, Chase, Marianne, Sherman, Alex, Yu, Hong, Pothier, Lindsay, Drake, Kristin, Chibnik, Lori, Bind, Marie-Abele, Vestrucci, Matteo, McGlothlin, Anna, Marion, Joseph, Duda, Petra, Harvey, Brittany, Qureshi, Irfan, Donohue, Mary, Granit, Volkan, Grossman, Katheryn, Glanzman, Robert, Hotchkin, Michael, Goldberg, Y Paul, Leitner, Melanie, Hayden, Michael, Cudkowicz, Merit

Volltext

Unique Composition of CNM-Au8 to Treat MS and ALS: Michael Hotchkin von Hotchkin, Michael

Volltext

CNM-Au8's Impact on Survival, Energetic Dysfunction in ALS: Michael Hotchkin von Hotchkin, Michael

Volltext

2318 Evidence for a survival benefit with long term CNM-Au8 treatment: open-label follow-up of the Australian RESCUE-ALS trial von Vucic, Steve, Menon, Parvathi, Ho, Karen S, Huynh, William, Mahoney, Colin, Glanzman, Robert, Hotchkin, Michael, Kiernan, Matthew

Volltext

2322 Results of the Australian RESCUE-ALS trial: a phase 2, randomized, double-blind, placebo-controlled study of CNM-Au8 to slow disease progression in ALS von Vucic, Steve, Menon, Parvathi, Huynh, William, Mahoney, Colin, Ho, Karen S, Glanzman, Robert, Hotchkin, Michael, Kiernan, Matthew

Volltext

Protein Corona Composition of Gold Nanocatalysts von Ashkarran, Ali Akbar, Tadjiki, Soheyl, Lin, Zijin, Hilsen, Kylie, Ghazali, Noor, Krikor, Sarah, Sharifi, Shahriar, Asgari, Meisam, Hotchkin, Michael, Dorfman, Adam, Ho, Karen S., Mahmoudi, Morteza

Volltext

Study protocol of RESCUE-ALS: A Phase 2, r andomised, double-blind, placebo-controlled study in e arly s ymptomatic amyotrophic lateral sclerosis patients to assess bioenergetic c... von Vucic, Steve, Kiernan, Matthew C, Menon, Parvathi, Huynh, William, Rynders, Austin, Ho, Karen S, Glanzman, Robert, Hotchkin, Michael T

Volltext

Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extensionResearch i... von Steve Vucic, Parvathi Menon, William Huynh, Colin Mahoney, Karen S. Ho, Alan Hartford, Austin Rynders, Jacob Evan, Jeremy Evan, Shelia Ligozio, Robert Glanzman, Michael T. Hotchkin, Matthew C. Kiernan

Volltext

Therapeutic justice in Alaska's courts von Carns, Teresa W, Hotchkin, Michael G, Andrews, Elaine M

Volltext